316
Participants
Start Date
June 13, 2025
Primary Completion Date
June 30, 2027
Study Completion Date
June 30, 2029
Milrinone infusion
An intravenous (iv) infusion of milrinone will be administered at an initial dose of 0.33 mcg/kg/min and accompanied by an iv bolus of 10 mL/kg of 0.9% NaCl (administered over 60 minutes).
Placebo infusion
An iv infusion of placebo (0.9% saline) of equivalent volume will be administered. The infusion will be accompanied by an iv bolus of 10 mL/kg of 0.9% NaCl (administered over 60 minutes) to ensure blinding is maintained.
NOT_YET_RECRUITING
University of Pennsylvania, Philadelphia
NOT_YET_RECRUITING
Duke University, Durham
NOT_YET_RECRUITING
Emory University, Atlanta
NOT_YET_RECRUITING
University of Alabama - Birmingham, Birmingham
NOT_YET_RECRUITING
Le Bonheur Children's Hospital, Memphis
NOT_YET_RECRUITING
University of Mississippi Medical Center, Jackson
NOT_YET_RECRUITING
Case Western Reserve University, Cleveland
NOT_YET_RECRUITING
Cincinnati Children's Hospital Medical Center, Cincinnati
NOT_YET_RECRUITING
University of Iowa, Iowa City
RECRUITING
Northwestern Lurie Children's Hospital of Chicago, Chicago
NOT_YET_RECRUITING
University of Oklahoma Health Sciences, Oklahoma City
NOT_YET_RECRUITING
University of Texas Southwestern, Dallas
NOT_YET_RECRUITING
University of Texas at Houston, Houston
NOT_YET_RECRUITING
University of Utah, Salt Lake City
NOT_YET_RECRUITING
University of New Mexico, Albuquerque
NOT_YET_RECRUITING
Sharp Mary Birch Hospital for Women & Newborns, San Diego
NOT_YET_RECRUITING
Children's Hospital of Orange County, Orange
NOT_YET_RECRUITING
Stanford University, Palo Alto
NOT_YET_RECRUITING
Boston Children's Hospital, Boston
National Heart, Lung, and Blood Institute (NHLBI)
NIH
NICHD Neonatal Research Network
NETWORK